...
首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >Downregulation of Nuclear Factor Erythroid 2鈥揜elated Factor and Associated Antioxidant Genes Contributes to Redox-Sensitive Vascular Dysfunction in HypertensionNovelty and Significance
【24h】

Downregulation of Nuclear Factor Erythroid 2鈥揜elated Factor and Associated Antioxidant Genes Contributes to Redox-Sensitive Vascular Dysfunction in HypertensionNovelty and Significance

机译:核因子类红细胞2'相关因子和相关抗氧化基因的下调有助于高血压中氧化还原敏感性血管功能障碍的意义和意义

获取原文

摘要

Oxidative stress is implicated in vascular dysfunction in hypertension. Although mechanisms regulating vascular pro-oxidants are emerging, there is a paucity of information on antioxidant systems, particularly nuclear factor erythroid 2鈥搑elated factor (Nrf2), a master regulator of antioxidants enzymes. We evaluated the vascular regulatory role of Nrf2 in hypertension and examined molecular mechanisms, whereby Nrf2 influences redox signaling in small arteries and vascular smooth muscle cells from Wistar Kyoto (WKY) and stroke-prone spontaneously hypertensive rats (SHRSP). Cells were stimulated with angiotensin II in the absence/presence of Nrf2 activators (bardoxolone/L-sulforaphane). Increased vascular reactive oxygen species production (chemiluminescence and amplex red) was associated with reduced Nrf2 activity in arteries (18%) and vascular smooth muscle cells (48%) in SHRSP ( P <0.05 versus WKY). Expression of antioxidant enzymes, including superoxide dismutase-1 (64%), catalase (60%), peroxiredoxin 1 (75%), and glutathione peroxidase (54%), was reduced in SHRSP. L-sulforaphane reversed these effects. Angiotensin II increased nuclear accumulation of Nrf2 in vascular smooth muscle cells from WKY (197% versus vehicle), with blunted effects in SHRSP (44% versus vehicle). These responses were associated with increased antioxidant expression (superoxide dismutase-1, 32%; catalase, 42%; thioredoxin, 71%; peroxiredoxin, 1%鈥?0%; quinone oxidoreductase, 84%; P <0.05 versus vehicle) and increased activity of superoxide dismutase-1, catalase, and thioredoxin in WKY but not in SHRSP, which exhibited increased Bach1 expression. Nrf2 activators blocked angiotensin II鈥搃nduced reactive oxygen species generation. Vascular function demonstrated increased contractility ( E max WKY 113.4卤5.6 versus SHRSP 159.0卤8.3) and decreased endothelial-dependent relaxation ( E max WKY 88.6卤3.1 versus SHRSP 74.6卤3.2, P <0.05) in SHRSP, effects corrected by L-sulforaphane. Our findings suggest that Nrf2 downregulation contributes to redox-sensitive vascular dysfunction in hypertension.# Novelty and Significance {#article-title-41}
机译:氧化应激与高血压中的血管功能障碍有关。尽管调节血管促氧化剂的机制正在出现,但是关于抗氧化剂系统的信息很少,特别是抗氧化剂酶的主要调节剂核因子类红细胞2-脯氨酸因子(Nrf2)。我们评估了Nrf2在高血压中的血管调节作用,并研究了分子机制,由此Nrf2影响了来自Wistar Kyoto(WKY)和易发中风自发性高血压大鼠(SHRSP)的小动脉和血管平滑肌细胞中的氧化还原信号。在缺少/存在Nrf2激活剂(巴多索隆/ L-萝卜硫烷)的情况下,用血管紧张素II刺激细胞。在SHRSP中,血管中活性氧的产生增加(化学发光和朱红色)与Nrf2活性降低(18%)和血管平滑肌细胞(48%)相关(P <0.05 vs WKY)。 SHRSP中抗氧化酶的表达降低,包括超氧化物歧化酶-1(64%),过氧化氢酶(60%),过氧化物酶1(75%)和谷胱甘肽过氧化物酶(54%)。 L-萝卜硫烷逆转了这些作用。血管紧张素II增加了来自WKY的血管平滑肌细胞中Nrf2的核积累(相对于媒介物为197%),对SHRSP的作用较弱(相对于媒介物为44%)。这些反应与抗氧化剂的表达增加有关(超氧化物歧化酶-1,32%,过氧化氢酶42%,硫氧还蛋白71%,过氧化物酶,1%〜0%,醌氧化还原酶,84% %;相对于媒介物,P <0.05),并且WKY中超氧化物歧化酶-1,过氧化氢酶和硫氧还蛋白的活性增加,而SHRSP中则没有,这表明Bach1表达增加。 Nrf2激活剂阻断了血管紧张素II诱导的活性氧的生成。血管功能证明SHRSP的收缩力增强(E max WKY 113.4±5.6 vs SHRSP 159.0±8.3)和内皮依赖性舒张功能降低(E max WKY 88.6±3.1 vs SHRSP 74.6±3.2,P <0.05),L-萝卜硫素可纠正这种作用。我们的发现表明,Nrf2的下调会导致高血压中氧化还原敏感的血管功能障碍。#新颖性和意义{#article-title-41}

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号